Codexis (CDXS) Change in Acquisitions & Divestments (2010 - 2026)
Codexis' quarterly Change in Acquisitions & Divestments came in at $19.1 million in Q1 2026, down 18.24% year-on-year from $23.3 million in Q1 2025, and down 77.57% quarter-over-quarter from $85.1 million in Q4 2025.
Codexis has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $19.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 18.24% year-over-year to $19.1 million; the trailing twelve-month figure through Mar 2026 stood at $80.9 million (up 37.41% YoY), and the FY2025 full-year result was $85.1 million, up 139.79% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $19.1 million, down from $85.1 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $85.1 million in Q4 2025, with the low at -$39.4 million in Q3 2025.
- Average Change in Acquisitions & Divestments over 3 years is $17.5 million, with a median of $17.5 million recorded in 2025.
- Peak annual rise in Change in Acquisitions & Divestments reached 433.33% in 2025, while the deepest fall reached 3731.55% in 2025.
- Tracing CDXS's Change in Acquisitions & Divestments over 3 years: stood at $33.5 million in 2024, then surged by 153.9% to $85.1 million in 2025, then slumped by 77.57% to $19.1 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $19.1 million (Q1 2026), $85.1 million (Q4 2025), and -$39.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Codexis | 251.43 Mn | 186.29 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.09 Mn |
| Mar 31, 2026 | 19.09 Mn |
| Dec 31, 2025 | 85.13 Mn |
| Dec 31, 2025 | 85.13 Mn |
| Sep 30, 2025 | -39.35 Mn |
| Sep 30, 2025 | -39.35 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Mar 31, 2025 | 23.35 Mn |
| Mar 31, 2025 | 23.35 Mn |
| Dec 31, 2024 | 33.53 Mn |
| Dec 31, 2024 | 33.53 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Jun 30, 2014 | 1.00 Mn |
| Jun 30, 2014 | 1.00 Mn |
| Mar 31, 2014 | 2.00 Mn |
| Mar 31, 2014 | 2.00 Mn |
| Dec 31, 2013 | -1,000.00 |
| Dec 31, 2013 | -1,000.00 |
| Sep 30, 2013 | 2.50 Mn |
| Sep 30, 2013 | 2.50 Mn |
| Jun 30, 2013 | 8.41 Mn |
| Jun 30, 2013 | 8.41 Mn |
| Mar 31, 2013 | 2.50 Mn |
| Mar 31, 2013 | 2.50 Mn |
| Dec 31, 2012 | 9.09 Mn |
| Dec 31, 2012 | 9.09 Mn |
| Sep 30, 2012 | 15.84 Mn |
| Sep 30, 2012 | 15.84 Mn |
| Jun 30, 2012 | -1.06 Mn |
| Jun 30, 2012 | -1.06 Mn |
| Mar 31, 2012 | 6.02 Mn |
| Mar 31, 2012 | 6.02 Mn |
| Dec 31, 2011 | 2.00 Mn |
| Dec 31, 2011 | 2.00 Mn |
| Dec 31, 2010 | -1,000.00 |
| Dec 31, 2010 | -1,000.00 |
| Sep 30, 2010 | 48.74 Mn |
| Sep 30, 2010 | 48.74 Mn |